Search research articles
Contact Us
Filters
Showing results (11-20 of 39) with videos related to
Page
of 4
Sort By:
Pharmaceutical Patent Analyst
|
March 5, 2014
Ca(2+) release-activated Ca(2+) channel inhibitors
Paolo Pevarello, Silvia Cainarca, Chiara Liberati, et al.
Pharmaceutical Patent Analyst
|
November 19, 2015
FFA4/GPR120 agonists: a survey of the recent patent literature
Rosa Formicola, Paolo Pevarello, Christina Kuhn, et al.
International Journal of Medical Sciences
|
February 21, 2013
Ten-week whole-body vibration training improves body composition and muscle strength in obese women
Chiara Milanese, Francesco Piscitelli, Maria Grazia Zenti, et al.
Plos One
|
February 1, 2018
Metabolic effect of bodyweight whole-body vibration in a 20-min exercise session: A crossover study using verified vibration stimulus
Chiara Milanese, Valentina Cavedon, Marco Sandri, et al.
Journal of Applied Crystallography
|
September 19, 2013
A novel small-angle neutron scattering detector geometry
Kalliopi Kanaki, Andrew Jackson, Richard Hall-Wilton, et al.
Journal of Applied Crystallography
|
September 27, 2013
Erratum: A novel small-angle neutron scattering detector geometry. Corrigendum
Kalliopi Kanaki, Andrew Jackson, Richard Hall-Wilton, et al.
Talanta
|
August 31, 2010
Enantioselective HPLC combined with spectroscopic methods: a valid strategy to determine the absolute configuration of potential beta-secretase inhibitors
Roberto Cirilli, Rosella Ferretti, Giuseppe La Regina, et al.
Antiviral Chemistry & Chemotherapy
|
November 19, 2011
Mechanism of interaction of novel indolylarylsulfone derivatives with K103N and Y181I mutant HIV-1 reverse transcriptase in complex with its substrates
Alberta Samuele, Sara Bisi, Alexandra Kataropoulou, et al.
Antiviral Research
|
November 6, 2008
Non-nucleoside HIV-1 reverse transcriptase inhibitors di-halo-indolyl aryl sulfones achieve tight binding to drug-resistant mutants by targeting the enzyme-substrate complex
Alberta Samuele, Alexandra Kataropoulou, Marco Viola, et al.
Oncology Letters
|
September 12, 2012
Arylthioindoles: Promising compounds against cancer cell proliferation
Vincenzo Giansanti, Francesco Piscitelli, Tania Camboni, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 39) with videos related to
Sort By:
Page
of 4
Pharmaceutical Patent Analyst
|
March 5, 2014
Ca(2+) release-activated Ca(2+) channel inhibitors
Paolo Pevarello, Silvia Cainarca, Chiara Liberati, et al.
Pharmaceutical Patent Analyst
|
November 19, 2015
FFA4/GPR120 agonists: a survey of the recent patent literature
Rosa Formicola, Paolo Pevarello, Christina Kuhn, et al.
International Journal of Medical Sciences
|
February 21, 2013
Ten-week whole-body vibration training improves body composition and muscle strength in obese women
Chiara Milanese, Francesco Piscitelli, Maria Grazia Zenti, et al.
Plos One
|
February 1, 2018
Metabolic effect of bodyweight whole-body vibration in a 20-min exercise session: A crossover study using verified vibration stimulus
Chiara Milanese, Valentina Cavedon, Marco Sandri, et al.
Journal of Applied Crystallography
|
September 19, 2013
A novel small-angle neutron scattering detector geometry
Kalliopi Kanaki, Andrew Jackson, Richard Hall-Wilton, et al.
Journal of Applied Crystallography
|
September 27, 2013
Erratum: A novel small-angle neutron scattering detector geometry. Corrigendum
Kalliopi Kanaki, Andrew Jackson, Richard Hall-Wilton, et al.
Talanta
|
August 31, 2010
Enantioselective HPLC combined with spectroscopic methods: a valid strategy to determine the absolute configuration of potential beta-secretase inhibitors
Roberto Cirilli, Rosella Ferretti, Giuseppe La Regina, et al.
Antiviral Chemistry & Chemotherapy
|
November 19, 2011
Mechanism of interaction of novel indolylarylsulfone derivatives with K103N and Y181I mutant HIV-1 reverse transcriptase in complex with its substrates
Alberta Samuele, Sara Bisi, Alexandra Kataropoulou, et al.
Antiviral Research
|
November 6, 2008
Non-nucleoside HIV-1 reverse transcriptase inhibitors di-halo-indolyl aryl sulfones achieve tight binding to drug-resistant mutants by targeting the enzyme-substrate complex
Alberta Samuele, Alexandra Kataropoulou, Marco Viola, et al.
Oncology Letters
|
September 12, 2012
Arylthioindoles: Promising compounds against cancer cell proliferation
Vincenzo Giansanti, Francesco Piscitelli, Tania Camboni, et al.
Page
of 4